Vitamin e derivative tested to stall liver failure in cirrhosis patients
NCT ID NCT02581085
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 21 times
Summary
This study tests whether a natural compound called tocotrienol (a form of vitamin E) can slow the worsening of end-stage liver disease in 70 adults with cirrhosis. Participants take either tocotrienol capsules or a placebo twice daily for 3 years. The goal is to see if the treatment prevents rises in a key liver score (MELD) and reduces complications like liver failure or need for transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IU Health Unviersity Hospital
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.